TEVA-DASATINIB
As listed in the register: TEVA-DASATINIB
20 mg · tablet
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Dasatinib (Dasatinib Monohydrate)
- Made by
- Teva Canada Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Bulgaria2 matching products
European UnionNo exact match for this strength and form
Spain6 matching products
- SPRYCEL 20 mg · comprimido recubierto con película2 makers
- DASATINIB ACCORD 20 mg · comprimido recubierto con película
- DASATINIB ACCORD HEALTHCARE 20 mg · comprimido recubierto con película
- DASATINIB TEVA 20 mg · comprimido recubierto con película
- DASATINIB VIATRIS 20 mg · comprimido recubierto con película
Netherlands11 matching products
- Dasatinib Synthon 20 mg 20 mg · filmomhulde tablet2 makers
- Dasatinib Accord Healthcare 20 mg filmomhulde tabletten 20 mg · filmomhulde tablet
- Dasatinib CF 20 mg 20 mg · filmomhulde tablet
- Dasatinib Krka 20 mg filmomhulde tabletten 20 mg · filmomhulde tablet
- Dasatinib Sandoz 20 mg 20 mg · filmomhulde tablet
- Dasatinib Teva 20 mg 20 mg · filmomhulde tablet
- Dasatinib Viatris 20 mg 20 mg · filmomhulde tablet
- Dasatinib Vivanta 20 mg filmomhulde tabletten 20 mg · filmomhulde tablet
SwitzerlandNo exact match for this strength and form
Details
| Made by | Teva Canada Limited |
|---|---|
| Active substance | Dasatinib (Dasatinib Monohydrate) |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 20 mg |
| Form | tablet |
| Classification | L01EA02 · Cancer treatments and immune-system medicines |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02478307 |
| DPD drug code | 96907 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
5 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.